Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Ketamine for Acute Pain Crisis in Patients With Sickle Cell Disease

NCT04330183 is registered in ClinicalTrials.gov with Rhode Island Hospital as lead sponsor.

NCT NCT04330183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04330183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Ketamine for Acute Pain Crisis in Patients With Sickle Cell Disease
Lead sponsor
Rhode Island Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2020
Completion date
October 1, 2021
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell crisis